ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682298 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682298; 2) Community: the network communities that were significantly associated with the response to NSC 682298; 3) Molecule: the relationships between components within communities and NSC 682298; 4) MDR: the compounds that were significantly associated with the NSC 682298.

NSC Compound Enrichment Correlation
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.00792181575650994 0.70034451
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.00841144976667934 0.23013048
NSC 382049 2,4-Pyrimidinediamine, 6-ethyl-5-[3-nitro- 4-[(2-phenylethyl)amino]phenyl]- 0.00888636978630782 0.50406906
NSC 764043 (+)-JQ1 0.00940302282078408 0.15015148
NSC 169774 Bromocriptine methanesulfonate 0.0115521552688257 0.2421896
NSC 605756 Null 0.0115521552688257 0.1435646
NSC 628665 Null 0.0115521552688257 0.74848652
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0115521552688258 0.20578153
NSC 94600 Camptothecin 0.0115521552688258 0.79795902
NSC 626030 Naphth[2,3-d]oxazol-4-one, 2-(1,1-dimethylethyl)-9-[(4- fluorophenyl)imino]- 0.012374497233828 -0.16145879
Total:52  Current:12    [First] [Prev] [Next] [Last]